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sodium influx followed by cell swelling
Dietmar Steverding* and Darren W SextonAbstract
Background: The few currently available drugs for treatment of African trypanosomiasis are outdated and show
problems with toxicity and resistance. Hence, there is an urgent need for the discovery and development of new
anti-trypanosomal agents.
Findings: In this study, the ionophorous antibiotic salinomycin was investigated for its trypanocidal activity in vitro
using culture-adapted bloodstream forms of Trypanosoma brucei. The concentrations of salinomycin to reduce the
growth rate by 50% and to kill the parasites were 0.31 μM and 1 μM, respectively. The trypanocidal action of the
ionophore was shown to be the result of an influx of Na+ resulting in an increased intracellular Na+ concentration
followed by cell swelling. This mode of action differs from the mechanism for the anti-cancer activity of salinomycin
reported to be by induction of apoptosis.
Conclusion: Here we have shown that salinomycin is an effective agent against bloodstream forms of T. brucei and
might be a potential candidate for treatment of African trypanosomiasis.
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Background
African trypanosomes are the etiological agents of
sleeping sickness in humans and nagana disease in cattle.
The parasites are transmitted by the bite of infected tse-
tse flies and live and multiply in the blood and tissue
fluids of their mammalian hosts. Both sleeping sickness
and nagana disease occur in sub-Saharan Africa between
14° North and 20° South latitude, the distribution area of
tsetse flies [1]. In this so-called tsetse belt, millions of
people and cattle are at risk of getting infected with the
parasites [2,3]. In addition, it is estimated that nagana
disease costs the affected African countries over 1 billion
USD per year [3]. Chemotherapy of African trypanoso-
miasis still relies on a few drugs developed decades ago,
most of which show poor efficacy and significant toxicity,
and are being increasingly subject to drug resistance [4].
Thus, new drugs are urgently needed for chemotherapy of
sleeping sickness and nagana disease. One approach for
the discovery of new drugs for treatment of African* Correspondence: D.Steverding@uea.ac.uk
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distribution, and reproduction in any mediumtrypanosomiasis is the screening of existing drugs for
trypanocidal activities [5].
Salinomycin (Figure 1) is a carboxylic polyether anti-
biotic produced by a strain of Streptomyces albus [6]. It is a
monovalent cation ionophore mediating the transport of
Na+, K+ and Rb+ (but not of Cs+, Mg2+, Ca2+ and Sr2+)
across organic phases [7]. The antibiotic is widely used as a
food supplement to control coccidiosis in poultry [8,9] and
has recently received attention as a novel cancer drug can-
didate [10]. However, compounds displaying anti-cancer
activity usually also exhibit strong trypanocidal activity
[11-13]. In this study, we investigated the trypanocidal
activity of salinomycin and the underlying mechanism
of action of the antibiotic using bloodstream forms of
Trypanosoma brucei.
Methods
The trypanocidal activity of salinomycin was determined
with bloodstream forms of the T. brucei clone 427–221
[14] while the general cytotoxicity of the ionophore was
evaluated with human HL-60 cells and normal PBMCs
(peripheral blood mononuclear cells). Cells were seeded
in 24-well plates in a final volume of 1 ml of appropriate
culture medium (trypanosomes: Baltz medium [15];ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Structure of salinomycin.
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16.7% (v/v) heat-inactivated foetal bovine serum and
containing various concentrations of salinomycin (10-4 to
10-9 M) and 1% DMSO. Wells containing medium and 1%
DMSO served as controls. The initial cell densities were
1 × 104/ml for trypanosomes, 1 × 105/ml for HL-60 cells
and 5 × 105/ml for PBMCs. After 24 h incubation, 100 μl
of a 0.44 mM resazurin solution prepared in PBS was
added and the cells were incubated for a further 48 h.
Thereafter, the plates were read on a microplate reader
using a test wavelength of 570 nm and a reference wave-
length of 630 nm. The 50% growth inhibition (GI50) value
(trypanosomes and HL-60 cells) and the 50% effective
concentration (EC50) value (PBMCs), i.e., the concentra-
tion of salinomycin necessary to reduce the growth rate of
cells by 50% or to cause an effect in 50% of cells compared
to the control, were determined from mean values using
the 4-parameter logistic model [17]. The following
formula for the 4-parameter logistic model was used: Y =
{[a-d]/[1 + (X/c)b]} + d, where Y is the response, X is the
concentration, a is the lower asymptote (lower plateau), d
is the upper asymptote (upper plateau), b is the slope fac-
tor (Hill factor) and c is the GI50/EC50 value. The mini-
mum inhibitory concentration (MIC) value, i.e. the con-
centration of salinomycin at which all cells were killed,
was determined microscopically by inspecting each well
thoroughly for the presence of any motile trypanosomes
or unlysed HL-60s or PBMCs.
Changes in cell volume were measured using a previously
described light scattering method [18]. Bloodstream forms
of T. brucei were seeded at a density of 5 × 107 cells/ml in
96-well plates in a final volume of 200 μl culture medium
containing 100 μM salinomycin and 0.5% DMSO (test) or
0.5% DMSO alone (control). Absorbance of the cultures
was measured at 490 nm every 15 min. A decrease in ab-
sorbance corresponded to an increase in cell volume.Cell morphology changes were examined by light micros-
copy. Briefly, bloodstream forms of T. brucei were treated
at a density of 5 × 107 cells/ml with 100 μM salinomycin
and 0.5% DMSO (test) or 0.5% DMSO alone (control).
After 1 h incubation, cells were fixed with 2% formalde-
hyde/0.05% glutaraldehyde in PBS, spread onto slides and
air dried. The smears were stained with May-Grünwald
staining solution and then imaged with a Zeiss Axioplan
2 fluorescence microscope using a Plan-Apochromat
100×/1.4 oil objective.
The intracellular level of Na+ was monitored with So-
dium Green™ tetraacetate, a cell-permeant indicator for
the fluorometric determination of Na+ concentration. The
probe can freely diffuse across cell membranes and is
intracellularly converted into the Na+-responsive acidic
form by esterases. Trypanosomes were incubated at a
density of 5 × 107 cells/ml with 100 μM salinomycin and
0.5% DMSO (test) or 0.5% DMSO alone (control) in the
presence of 4 μM Sodium Green™ tetraacetate for 1 h.
After washing twice with culture medium, cells were then
immediately analysed by flow cytometry using a BD
Accuri C6 flow cytometer. The excitation wavelength was
488 nm and the filter set was 530/30 nm. Gates were set
to exclude cell fragments and debris from the analysis,
and 50,000 gated cells were analysed.
Results and discussion
Salinomycin showed a dose-dependent effect on the
growth of T. brucei bloodstream forms with a GI50 value
of 0.17 μM and a MIC value of 1 μM (Figure 2). The
ionophore displayed similar cytotoxic activity against
leukaemic HL-60 cells with a GI50 value of 0.29 μM and
a MIC value of 1 μM (Figure 2). Similar antiproliferative
activity has been recently reported for various other can-
cer cells including human promyelocytic leukaemia cells
(IC50 = 0.44 μM [19]), human colon adenocarcinoma
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Figure 2 Trypanocidal and cytotoxic effects of salinomycin. Bloodstream forms of T. brucei (red squares), HL-60 cells (green circles) and
PBMCs (blue triangles) were incubated with varying concentrations of salinomycin. After 72 h of culture, cell viability and proliferation were
determined with the colorimetric dye resazurin. Mean values ± SD of three (PBMCs) or four (T. brucei and HL-60) experiments are shown. Dose–response
curves were calculated from mean values using the 4-parameter logistic model.
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Figure 3 Effect of salinomycin on the cell volume of
bloodstream forms of T. brucei. Trypanosomes (5 × 107 cell/ml)
were incubated in the absence (circles) or presence (squares) of
100 μM salinomycin in culture medium. Every 15 min the
absorbance at 490 nm was measured. Note that a decrease in
absorbance corresponds to an increase in cell volume. Mean values
± SD of three experiments are shown.
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cells (EC50 = 0.38 μM [20]). In contrast to the effect on
cancer cells, it was reported that salinomycin is 10–100
times less cytotoxic against non-malignant cells [19,20].
In fact, salinomycin exhibited only low cytotoxicity a-
gainst normal PBMCs with an EC50 value of 29.9 μM
and a MIC value of 100 μM (Figure 2). This latter fin-
ding indicates that the ratio for cytotoxic/trypanocidal
activity (selectivity index) for salinomycin is in a mode-
rate range.
One obvious mechanism of action of salinomycin
would be its effect as an ionophore on the depolarisation
of membrane potentials. By using the fluorescent probe
3,3’-dihexyloxycarbocyanine, however, it was found that
salinomycin did not affect the membrane potential of
bloodstream forms of T. brucei (data not shown). This
observation is in agreement with previous findings that
valinomycin also did not influence the membrane poten-
tial of trypanosomes, although the parasites are ex-
tremely sensitive to this ionophore [21].
Another possible mechanism of action of salinomycin
could be that the ionophore increases the intracellular cat-
ion level followed by a quick entry of water which would
lead to cell swelling and damage of intracellular structures.
Changes in cell volume can be monitored spectrophoto-
metrically by following the absorbance of the cell suspen-
sion at 490 nm. Incubation of bloodstream forms of T.
brucei with 100 μM salinomycin resulted in a decrease of
absorbance over time while the absorbance of control cul-
tures did not change (Figure 3). It should be noted that a
much higher concentration of salinomycin was needed
(100 μM compared to 1 μM necessary to kill all cells inthe growth inhibition assay shown in Figure 2) in order to
observe a measurable effect on the swelling of trypano-
somes in a short period of time. This is because that at
high cell density, which is required for the recording of
changes in cell volume, bloodstream forms of T. brucei do
not survive for a very long time in culture. The decrease
in absorbance corresponded to cell swelling as judged
from visual observation by light microscopy. Parasites
treated for 1 h with 100 μM salinomycin lost the normal
elongated shape of trypanosomes and appeared as
rounded up cells (Figure 4). The only monovalent cations
Figure 5 Effect of salinomycin on intracellular Na+ levels in
bloodstream forms of T. brucei. Trypanosomes (5 × 107 cell/ml)
were incubated with 4 μM Sodium Green™ tetraacetate in the
absence (black line) or presence (red line) of 100 μM salinomycin.
After 1 h incubation, trypanosomes were washed with culture
medium and analysed by flow cytometry. A representative
experiment out of three is shown.
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culture medium are Na+ and K+. Thus, only these may be
involved in the cell swelling observed in the presence of
salinomycin. As bloodstream forms of T. brucei are low-
Na+ and high-K+ cells [22], only a salinomycin-mediated
transport of Na+ from the exterior to the interior could
explain the observed cell swelling. To prove that the cause
of the swelling was indeed due to an increased intracellu-
lar Na+ level, the concentration of Na+ was determined
with the fluorescent probe Sodium Green™ tetraacetate.
Subsequent flow cytometry revealed that trypanosomes
treated with 100 μM salinomycin for 1 h had a much
higher fluorescence signal than control cells (Figure 5).
The median fluorescence intensity signal for salinomycin-
treated parasites was 2223 ± 164 (n = 3) and for control
parasites it was 1050 ± 345 (n = 3). This result indicates
that upon incubation with salinomycin, the intracellular
Na+ concentration was raised more than twofold in the
trypanosomes from 13.7 mM [22] to about 30 mM. This
increase in Na+ concentration is enough to explain the
swelling of trypanosomes by entry of water. For instance,
subjection of bloodstream forms of T. brucei to a reduc-
tion in osmolarity from 300 to 150 mOsm (which in turn
can be regarded as a twofold increase in the intracellular
concentration of solute particles) results in a dramatic ini-
tial swelling of the cells [23].
Conclusion
This study has demonstrated that the ionophore sali-
nomycin displays trypanocidal activity by a mechanism in-
volving increased Na+ influx followed by subsequent cell
swelling which is probably due to the uptake of water.
This mechanism is different from the mode of action
reported for the anti-cancer activity of salinomycin.
Recent research has shown that salinomycin induces
apoptosis in cancer cells by different mechanisms, which
include increasing the intracellular levels of reactive oxy-
gen species (ROS) [24] and inhibiting the Wnt signalling
pathway [25]. However, we did not find any evidence thatA
Figure 4 Effect of salinomycin on the morphology of bloodstream fo
absence (A) or presence (B) of 100 μM salinomycin for 1 h. Formaldehyde/
stained with May-Grünwald staining solution. A representative experimentthe trypanocidal activity of salinomycin is associated with
the induction of apoptosis in bloodstream forms of T.
brucei (data not shown).
Importantly, salinomycin can be administered orally
whereas most of the current drugs used for treatment of
African trypanosomiasis have to be given parenterally. Be-
fore developing salinomycin into an anti-trypanosomal
agent, animal experiments are needed to establish the
in vivo trypanocidal activity of the ionophore. However, a
selectivity index of 10–100 may be inadequate for pro-
ceeding with animal studies as it is recommended that
such animal experiments should only be pursued if the se-
lectivity index is greater than 100 [26]. Despite this,
salinomycin may serve as a lead for the development ofB
rms of T. brucei. Trypanosomes (5 × 107 cell/ml) were incubated in the
glutaraldehyde-fixed cells were spread onto slides, air dried and
out of three is shown.
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dition, the ionophore could be used in combination with
current anti-trypanosomal drugs. In recent years, such a
drug combination regime (eflornithine/nifurtimox) has
been successfully introduced for the treatment of human
African sleeping sickness [27].
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